Filing Details

Accession Number:
0001209191-23-002439
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 17:54:54
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 17:54:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230482 W Jeffrey Sherman C/O Horizon Therapeutics Plc,
70 St. Stephen?S Green
Dublin L2 D02 E2X4
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2023-01-05 51,132 $0.00 65,562 No 4 M Direct
Ordinary Shares Disposition 2023-01-05 22,655 $113.24 42,907 No 4 F Direct
Ordinary Shares Disposition 2023-01-06 5,187 $113.29 49,314 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units (RSUs) Acquisiton 2023-01-04 18,397 $0.00 18,397 $0.00
Ordinary Shares Restricted Stock Units (RSUs) Disposition 2023-01-05 12,095 $0.00 12,095 $0.00
Ordinary Shares Restricted Stock Units (RSUs) Disposition 2023-01-05 9,314 $0.00 9,314 $0.00
Ordinary Shares Restricted Stock Units (RSUs) Disposition 2023-01-05 6,348 $0.00 6,348 $0.00
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2023-01-05 7,257 $0.00 7,257 $0.00
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2023-01-05 1,966 $0.00 1,966 $0.00
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2023-01-05 4,834 $0.00 4,834 $0.00
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2023-01-05 9,318 $0.00 9,318 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,397 No 4 A Direct
0 No 4 M Direct
9,314 No 4 M Direct
12,696 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
4,654 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 84,430 Indirect See Footnote
Ordinary Shares 66,730 Indirect by Spouse
Footnotes
  1. Each RSU/PSU represents a contingent right to receive one ordinary share of the Issuer.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
  3. The shares are held in the Jeffrey W. Sherman Living Trust.
  4. The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
  5. The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
  6. The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
  7. The remaining ordinary shares subject to the RSU vest on January 5, 2024.
  8. The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.
  9. The ordinary shares subject to the PSUs vested on January 5, 2023.
  10. The remaining ordinary shares subject to the PSU vest on January 5, 2024.